The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
MJFF Research Grant, 2010Patient-specific iPS cell-derived Neurons and Disease-associated LRRK2 Mutations for Parkinson's Disease Research
Objective/Rationale:
Several underlying genetic risk factors are now established for Parkinson’s disease (PD). Mutations in LRRK2 are the most common genetic cause of the selective neurodegeneration... -
MJFF Research Grant, 2010Male transgenic rat Parkinson's disease model characterization
Promising Outcomes of Original Grant:
The original project focused on the creation and characterization of pre-clinical models that express mutations in the protein alpha-synuclein that are known to... -
Rapid Response Innovation Awards, 2010The Role of Alpha-synuclein in the Pathogenesis of Parkinson's Disease in a Pre-clinical Model
Objective/Rationale:
We hypothesized that alpha-synuclein increased level and accumulation within the target neurons in the affected model acts as a trigger mechanism for activation of additional... -
MJFF Research Grant, 2010Clinical Assessment of Patients with PD Who Underwent DAT Scan and FDG PET at the Early Stages of Their Extra-Pyramidal Disorder as Part of Their Initial Workup
Objective/Rationale:
Ashkenazi Jewish PD patients in Israel have a 14% chance of carrying the G2019S LRRK2 mutation and 18% of carrying mutations in the GBA gene. Little is known on the association... -
MJFF Research Grant, 2010Delayed Start Assessment of Progranulin in a Progressive Rodent Model of Parkinson’s Disease
Promising Outcomes of Original Grant:
In preliminary development work, we demonstrated the capacity of the protein progranulin to protect against disease development in several pre-clinical model... -
MJFF Research Grant, 2010Coordinated Reset (CR) Stimulation of the Subthalamic Nucleus
Objective/Rationale:
Coordinated Reset (CR) stimulation improved locomotor activity in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridin (MPTP)-treated pre-clinical model in a “proof of concept” study...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.